Medicine and Dentistry
Human Papillomavirus Type 16
100%
S Phase
50%
Mitosis
50%
Oncoprotein
50%
Cyclin E
50%
Cyclin Dependent Kinase Inhibitor
50%
Cell Cycle Checkpoint
50%
Diagnosis
25%
Neoplasm
25%
Binding Site
25%
Wart Virus
25%
Protein Degradation
25%
Protein P53
25%
Cell Cycle
25%
P21
25%
Prematurity
25%
Cyclin D1
25%
G1/S Transition
25%
P16
25%
Mitosis Spindle
25%
Gene
25%
G2 Phase Cell Cycle Checkpoint
25%
Spindle Checkpoint
25%
Comprehension
25%
Aptitude
25%
Instability
25%
Biochemistry, Genetics and Molecular Biology
Human Papillomavirus Type 16
100%
Mitosis
50%
S Phase
50%
Cyclin-Dependent Kinase
50%
Cyclin E
50%
E2F
50%
Cell Cycle Checkpoint
50%
Nested Gene
25%
Binding Site
25%
P53
25%
Protein Catabolism
25%
Cell Cycle
25%
Spindle Checkpoint
25%
P16
25%
P21
25%
Wart Virus
25%
Cyclin D1
25%
Mitosis Spindle
25%
G1/S Transition
25%
G2 Phase Cell Cycle Checkpoint
25%
Aptitude
25%
Comprehension
25%
Genetics
25%
Protein Hydrolysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus Type 16
100%
Oncoprotein
50%
Cyclin Dependent Kinase Inhibitor
50%
Cyclin E
50%
Neoplasm
25%
Binding Site
25%
Prematurity
25%
Cyclin D1
25%
Protein P53
25%
Human Papillomavirus
25%